KVUE (kenvue.com) Market Value to Book Value Ratio

Official company branding of Kenvue Inc (KVUE)

Stable demand for daily health products ensures the resilience of Kenvue Inc. (KVUE), as confirmed by the market-to-book ratio, which currently stands at 3.54. This trend is supported by a global network of plants with optimized logistics and a team of top-tier researchers. A strong brand image guarantees reliability for employees and provides investors with protection against market volatility.

KVUE Kenvue Health: Market Value to Book Value in the range 02/21/2024 - 10/28/2026

Financial and market metric breakdowns for Kenvue Inc (KVUE)

- price and consensus price forecast:
Stock Price Kenvue Inc.|KVUE - Average Forecast Price
- market capitalization data:
Market Value Kenvue Corp|KVUE - Full Business Value
- book capitalization data:
Book Value per Share Kenvue|KVUE - Accounting Value of Company|Market Capitalization to Book Value Ratio kenvue.com|KVUE - Company Total Assets
- debt and liquidity data:
Debt to Equity Kenvue Inc.|KVUE - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Kenvue Corp|KVUE - Company Total Debt|Debts to Book Capitalization Kenvue Corp
Initial company analysis:Kenvue Inc. - KVUE
Original product of Kenvue Corp

This ratio reflects the market value premium over net assets, allowing investors to assess the actual value of the company's assets relative to exchange expectations. Analyzing the ratio of market capitalization to book value helps filter out speculative noise, which is critical for Kenvue Inc. (KVUE), as its capitalization is based on brand strength amid fierce competition from budget generics.

Main competitors

Market Capitalization to Book Value Ratio HLN|VRNA (veronapharma.com) - Market-to-Book Ratio|Market Value to Book Value Ratio Jyong Biotech MENS|Market Capitalization to Net Assets Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Market Capitalization to Book Value Ratio|Market Value to Book Value Perrigo Corp (PRGO)|Market Capitalization to Book Value Ratio ALVO (Alvotech)|liquidia.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Galapagos (GLPG)|ANIP: Market Value to Book Value|MNKD (MannKind Corp.) - Market Value to Book Value Ratio|Amphastar Corp (AMPH) - Market Cap to Net Assets Ratio|PCRX (Pacira BioSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Market Cap to Net Assets Ratio|Market Value to Book Value AQST (Aquestive Therapeutics Inc)|SCPH: Market Value to Book Value Ratio|TECX - Market-to-Book Ratio|Market Cap to Net Assets Ratio Tonix Pharmaceuticals TNXP|SXTC - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Market Value to Book Value|Market Capitalization to Book Value Ratio EXOZ (Invizyne Technologies, Inc.)|Market-to-Book Ratio ORMP|Entera Bio Ltd. (ENTX) - Market Value to Book Value Ratio|Market Value to Book Value HYFT (ipatherapeutics.com)|Market Value to Book Value Ratio ABVC (ABVC BioPharma, Inc.)|Market Capitalization to Book Value Ratio Cumberland Pharmaceuticals Inc CPIX|QNTM (Quantum BioPharma Limited) - Market Capitalization to Book Value Ratio|FGEN: Market-to-Book Ratio|Market Value to Book Value Ratio Telomir Pharmaceuticals|Capitalization to Book Value Ratio Rani Therapeutics Holdings, Inc.|Market Cap to Net Assets Ratio Synergy CHC Corp.|Market Value to Book Value Ratio Rallybio Corp. (RLYB)|Market Cap to Net Assets Ratio LEXX|Market Capitalization to Book Value Ratio Pulmatrix Corporation (PULM)|PTHL: Market Capitalization to Book Value Ratio|APM - Market-to-Book Ratio|Market Cap to Net Assets Ratio Lyra Therapeutics (LYRA)|IBO - Market Value to Book Value|tnfpharma.com - Market Capitalization to Book Value Ratio|YCBD (cbdMD) - Market Capitalization to Book Value|Market Value to Book Value Ratio PainReform Ltd. (PRFX)|Capitalization to Book Value Ratio Auris Medical|Market Capitalization to Book Value Ratio LIPO (Lipella Pharmaceuticals, Inc.)|Market Cap to Net Assets Ratio OptiNose Inc OPTN|Market Cap to Net Assets Ratio PIRS|Procaps Group Corp - Market Capitalization to Book Value|Petros Pharmaceuticals - Market Value to Book Value Ratio|qlsyy.net (QLI) - Market Capitalization to Book Value Ratio|ACELYRIN (SLRN) - Market Cap to Net Assets Ratio|Market Value to Book Value Ratio TFF Pharmaceuticals Inc.